Homeopathy and COVID 45: The Toothless Old Man Laughs

During the COVID-19 pandemic, almost every household object briefly auditioned for a medical career. Garlic became an antiviral. Steam inhalation became respiratory medicine. Supplements became “immune shields.” Somewhere in the commotion, tiny homeopathic pellets entered the room wearing an invisible lab coat.

The title Homeopathy and COVID 45: The Toothless Old Man Laughs comes from a satirical 2022 essay by infectious disease physician Mark Crislip. “COVID 45” was political-era wordplay, not the name of a virus, variant, diagnosis, or newly discovered disease. The original essay used pointed humor to criticize low-quality research and implausible claims about homeopathic COVID-19 remedies. Its reference to “Tooth Fairy Science” described research that attempts to measure a phenomenon before establishing that the phenomenon is real. >Beneath the jokes sits a serious public-health question: What happens when an unproven medical system is promoted during an infectious disease emergency? To answer it fairly, we must examine what homeopathy claims, what COVID studies actually showed, why weak research can look persuasive, and how patients can distinguish compassionate care from confident nonsense.

What Is Homeopathy?

Homeopathy was developed more than two centuries ago. Its central ideas include “like cures like,” meaning a substance believed to cause certain symptoms in a healthy person is used to treat similar symptoms in someone who is sick, and the “law of minimum dose,” which proposes that increasing dilution makes a remedy more powerful. Products may begin with plant, mineral, animal or chemical substances before undergoing repeated dilution and shaking, a process practitioners call potentization. >The dilution labels often use letters and numbers such as 6X, 30C or 200C. In a “C” preparation, one part of the starting mixture is generally diluted in 99 parts of liquid during each step. Repeat that process enough times and the probability of finding even one molecule of the original ingredient becomes extraordinarily small. At very high dilutions, the product may contain no measurable amount of the substance named on the label. Calling that concentration “gentle” is rather generous. “Absent” may be the more sociable word. 2>Why COVID-19 Became Fertile Ground for Homeopathic Claims

The early pandemic combined uncertainty, fear, overwhelmed hospitals, rapidly changing guidance and a public desperate for control. That environment rewarded simple answers. A treatment promising to be natural, personalized and free of frightening side effects could sound reassuring, especially when conventional medicine was still conducting trials and openly admitting what it did not know.

Some businesses promoted homeopathic products for COVID-19 prevention or treatment, including products described as “homeoprophylaxis.” The FDA issued warning letters to sellers whose marketing implied that unapproved products could prevent, mitigate, diagnose, treat or cure COVID-19. Federal regulators repeatedly emphasized that no homeopathic product had been approved by the FDA for treating or preventing any disease. >The appeal was not necessarily caused by foolishness. People facing a dangerous new disease wanted to protect their parents, children and communities. They also encountered an “infodemic” in which evidence, speculation, testimonials, political messaging and advertising arrived through the same glowing screen. The American Medical Association warned that health misinformation could create confusion, undermine public-health measures and encourage the use of unproven treatments. 2>A Published Study Is Not Automatically Good Evidence

Supporters sometimes point to articles indexed in medical databases as proof that homeopathy works. However, database inclusion means that a paper exists; it does not certify that its conclusions are correct. Research can be published with small samples, incomplete follow-up, unreliable measurements, unsuitable comparison groups or conclusions that exceed the data.

Several reports involving homeopathy and COVID-19 were observational studies or retrospective case series. In such research, patients may receive one or more homeopathic preparations while also receiving ordinary medical care. If they recover, the improvement is then associated with homeopathyeven though the study cannot reliably determine what caused the outcome. This is especially problematic with an illness from which many people recover without specialized treatment. 3>Natural Recovery Can Impersonate a Cure

People commonly try remedies when their symptoms feel worst. Many illnesses then improve because of the body’s natural course, a pattern related to regression toward the mean. The remedy receives the applause while biology quietly carries the piano offstage.

Suppose 100 people with mild COVID-19 take pellets on the third day of illness. Most recover during the following days. Without a properly selected control group, random assignment and consistent outcome measurements, researchers cannot tell whether the remedy accelerated recovery, did nothing or merely arrived shortly before improvement would have happened anyway.

Open-Label Studies Magnify Expectations

When participants and researchers know which treatment is being given, expectations can influence symptom reporting, follow-up decisions and interpretation. Randomized, double-blind, placebo-controlled trials help reduce these biases by preventing participants and investigators from knowing treatment assignments until the analysis is complete. Even well-designed trials require careful methods and appropriate placebos. >Subjective symptoms such as fatigue, discomfort, sleep quality and perceived breathing effort are particularly sensitive to expectations and attention. A caring consultation may help someone feel calmer and more supported. That experience can be valuable, but it does not prove that a highly diluted product has eliminated a virus, prevented pneumonia or changed the risk of hospitalization.

The Placebo Effect Is Realbut It Is Not an Antiviral

A placebo response is not simply imaginary. Expectations, therapeutic rituals and supportive interaction can influence pain, stress and other symptoms. Harvard Health notes that placebo effects may produce genuine perceived benefits. However, feeling better is not the same as stopping viral replication, preventing organ damage or reducing mortality. A friendly conversation can ease distress; it cannot negotiate with SARS-CoV-2 on behalf of your lungs. >This distinction matters because testimonials usually focus on experience: “I took it and felt better.” That statement may be completely sincere. It still cannot establish causation. To demonstrate that a treatment works, researchers must compare similar groups, define outcomes in advance, control for other treatments, report adverse events and reproduce the findings.

Homeopathic Products Are Not Always “Only Water”

Critics sometimes describe homeopathy as harmless because many products are extremely dilute. The safety picture is more complicated. Some products marketed as homeopathic have contained measurable quantities of active ingredients. Others may be incorrectly diluted or contaminated during manufacturing. Ingredients can include substances derived from belladonna, arsenic and other potentially toxic sources. Liquid preparations may also contain alcohol. >The larger danger may be opportunity cost. A person who relies on an unproven remedy may postpone testing, medical evaluation or time-sensitive antiviral treatment. That delay matters because effective COVID-19 medications must generally be started soon after symptoms begin. “It probably won’t hurt” is poor reassurance when the indirect risk is missing the window for something that could help. 2>How Regulators View Homeopathic Health Claims

Homeopathic products sold in the United States are subject to laws addressing drug approval, adulteration and misbranding, but they have not undergone FDA approval for safety and effectiveness. The FDA follows a risk-based enforcement strategy that prioritizes products associated with injuries, dangerous ingredients, serious diseases, vulnerable populations, nonstandard delivery routes or significant quality problems. >The Federal Trade Commission applies the same basic advertising standard to over-the-counter homeopathic products that it applies to comparable health products: objective claims require competent and reliable scientific evidence. The FTC has stated that unsupported marketing can be misleading, particularly when consumers are not clearly told that claims rely on traditional homeopathic theories rather than modern clinical evidence. >A Latin ingredient name, pharmacy-style packaging or a shelf location beside conventional medicine does not constitute FDA approval. Scientific-looking design is still design. A white box can contain excellent medicine, ineffective pellets or extremely ambitious typography.

What Evidence-Based COVID-19 Care Looks Like

At the time of writing in July 2026, the CDC advises people at higher risk of severe COVID-19 to contact a healthcare professional promptly because antiviral treatment generally must begin within five to seven days after symptoms start. Listed options for eligible patients include nirmatrelvir with ritonavir, commonly known as Paxlovid; intravenous remdesivir; and molnupiravir in selected adults. Treatment choice depends on age, medical risks, kidney or liver function, pregnancy considerations, medication interactions and other individual factors. >These treatments are not recommended because their names sound impressive. They are evaluated through laboratory research, controlled trials, safety monitoring and continuing evidence reviews. Recommendations can change as variants evolve and new data appear. That willingness to update is not a weakness of science. It is the maintenance schedule.

Yale Medicine and the Infectious Diseases Society of America likewise emphasize early antiviral treatment for appropriately selected patients at elevated risk. People should not borrow prescriptions, substitute veterinary products, or assume that “natural” and “safe” are synonyms. Medication interactions can be important, particularly with ritonavir-containing treatment, so professional review matters. >The NIH Office of Dietary Supplements reports that evidence remains insufficient to recommend vitamins, minerals, herbs or other dietary supplement ingredients as COVID-19 prevention or treatment. Correcting a diagnosed nutritional deficiency is legitimate healthcare. Tossing every bottle in the pantry at a respiratory virus is chemistry-themed confetti. 2>Complementary Care Is Not the Same as Alternative Care

It is useful to distinguish complementary care from alternative care. Complementary practices are used alongside appropriate medical treatment. Relaxation exercises, carefully selected physical activity, counseling, sleep support and rehabilitation may help people cope with stress or recover function. Alternative care replaces evidence-based treatment with an unproven substitute. That replacement is where risk climbs. >A patient can value compassionate conversation, cultural traditions and holistic support while still asking whether a specific product changes meaningful health outcomes. Respect for patients does not require respect for every claim sold to them.

Seven Questions to Ask Before Trusting a COVID Remedy

1. What exact outcome is promised? Symptom comfort, shorter illness, fewer hospitalizations and prevention of infection are different claims.
2. Was the treatment tested against an appropriate control? “Most patients improved” means little when most comparable patients would also improve.
3. Were participants randomly assigned? Without randomization, the groups may differ before treatment begins.
4. Were patients and investigators blinded? Expectations can affect reporting and interpretation.
5. How large was the study? Tiny studies produce unstable results and false-positive findings more easily.
6. Were all treatments and adverse events reported? A pellet should not receive sole credit when patients also received antivirals, oxygen, steroids or hospital care.
7. Has the result been independently reproduced? One exciting paper is a reason to investigate, not a reason to redesign medicine.

Humor Should Target Bad Claims, Not Frightened Patients

The humor in Homeopathy and COVID 45: The Toothless Old Man Laughs is sharp because the scientific criticism is sharp. Yet ridicule can backfire when it is aimed at patients. People often choose questionable remedies because they are afraid, exhausted, poorly served by the healthcare system or comforted by a practitioner who listens to them.

A better response combines empathy with clarity: acknowledge the person’s experience, explain why anecdotes cannot establish effectiveness, identify the risks of delay and offer an evidence-based plan. Medical misinformation is less likely to loosen its grip when someone feels humiliated. It is more likely to weaken when people receive understandable information from someone they trust. 2>Conclusion: When Nothing Is Marketed as Something

Homeopathy and COVID-19 created a perfect collision between an implausible medical theory and a frightened public searching for certainty. The resulting studies and testimonials often confused recovery with causation, association with proof and publication with validation.

The most important lesson is not that every unconventional idea must be mocked. New ideas deserve investigation. They do not deserve exemption from investigation. A treatment for a serious infectious disease should demonstrate meaningful benefits through rigorous, reproducible evidence. The smaller the proposed dose and the larger the proposed miracle, the more carefully we should check the receipt.

The toothless old man may laugh, but viruses do not respond to satire, sincerity or elegant packaging. They respond to biology. Our decisions should do the same.